Latest & greatest articles for fibromyalgia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on fibromyalgia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on fibromyalgia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for fibromyalgia

161. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis

Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

162. Treatment of fibromyalgia syndrome with gabapentin and pregabalin: a meta-analysis of randomized controlled trials

Treatment of fibromyalgia syndrome with gabapentin and pregabalin: a meta-analysis of randomized controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

163. Efficacy of hydrotherapy in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials

Efficacy of hydrotherapy in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

164. Effects of concurrent strength and endurance training on physical fitness and symptoms in postmenopausal women with fibromyalgia: a randomized controlled trial (PubMed)

Effects of concurrent strength and endurance training on physical fitness and symptoms in postmenopausal women with fibromyalgia: a randomized controlled trial To examine the effectiveness of concurrent strength and endurance training on muscle strength, aerobic and functional performance, and symptoms in postmenopausal women with fibromyalgia (FM).Randomized controlled trial.Local gym and university research laboratory.Twenty-six women with FM.Progressive and supervised 21-week concurrent

2008 EvidenceUpdates

165. A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome (Full text)

A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome To systematically review the efficacy of treatment of fibromyalgia syndrome (FMS) with antidepressants.We screened Medline, PsychINFO, SCOPUS, and the Cochrane Library databases (through October 2007) and the reference sections of original studies, meta-analyses, and evidence-based guidelines and recommendations on antidepressants in FMS. Randomized controlled trials (RCTs) on the treatment

2008 EvidenceUpdates PubMed

166. Ottawa Panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. (Full text)

Ottawa Panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. The objective of this study was to create guidelines for the use of aerobic fitness exercises in the management of adult patients (>18 years of age) with fibromyalgia, as defined by the 1990 American College of Rheumatology criteria.Following Cochrane Collaboration methods, the Ottawa Methods Group found and synthesized evidence from comparative controlled trials (...) Ottawa Panel recommends aerobic fitness exercises for the management of fibromyalgia as a result of the emerging evidence (grades A, B, and C+, although most trials were rated low quality) shown in the literature.

2008 EvidenceUpdates PubMed

167. Ottawa Panel evidence-based clinical practice guidelines for strengthening exercises in the management of fibromyalgia: part 2 (Full text)

Ottawa Panel evidence-based clinical practice guidelines for strengthening exercises in the management of fibromyalgia: part 2 The objective of this study was to create guidelines for the use of strengthening exercises in the management of adult patients (>18 years of age) with fibromyalgia (FM), as defined by the 1990 American College of Rheumatology criteria.Following Cochrane Collaboration methods, the Ottawa Methods Group found and synthesized evidence from comparative controlled trials (...) mean differences between the intervention and control groups, and dichotomous data were analyzed with relative risks. Clinical improvement was calculated using absolute benefit and relative difference in change from baseline. Clinical significance was attained when an improvement of 15% relative to a control was found.There were 5 positive recommendations: 2 grade A and 3 grade C+. All 5 were of clinical benefit.The Ottawa Panel recommends strengthening exercises for the management of fibromyalgia

2008 EvidenceUpdates PubMed

168. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial (PubMed)

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial The primary objectives of this study were to assess the efficacy and safety of duloxetine for reducing pain severity in fibromyalgia patients with or without current major depressive disorder. This was a 6-month, multicenter, randomized, double-blind, placebo-controlled study. In total, 520 (...) patients meeting American College of Rheumatology criteria for fibromyalgia were randomly assigned to duloxetine (20 mg/day, 60 mg/day, or 120 mg/day) or placebo, administered once daily, for 6 months (after 3 months, the duloxetine 20-mg/day group titrated to 60 mg/day). The co-primary outcome measures were the Brief Pain Inventory (BPI) average pain severity score and Patient Global Impressions of Improvement (PGI-I) score. Safety was assessed via treatment-emergent adverse events, and changes

2008 EvidenceUpdates

169. EULAR evidence-based recommendations for the management of fibromyalgia syndrome (Full text)

EULAR evidence-based recommendations for the management of fibromyalgia syndrome To develop evidence-based recommendations for the management of fibromyalgia syndrome.A multidisciplinary task force was formed representing 11 European countries. The design of the study, including search strategy, participants, interventions, outcome measures, data collection and analytical method, was defined at the outset. A systematic review was undertaken with the keywords "fibromyalgia", "treatment (...) or management" and "trial". Studies were excluded if they did not utilise the American College of Rheumatology classification criteria, were not clinical trials, or included patients with chronic fatigue syndrome or myalgic encephalomyelitis. Primary outcome measures were change in pain assessed by visual analogue scale and fibromyalgia impact questionnaire. The quality of the studies was categorised based on randomisation, blinding and allocation concealment. Only the highest quality studies were used

2008 EvidenceUpdates PubMed

170. A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome (Full text)

A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome Uceyler N, Hauser W, Sommer C CRD summary This review concluded that amitriptyline was effective in reducing the symptoms of patients with fibromyalgia syndrome, and some other antidepressants may (...) also be useful. Despite the methodological strengths of the review processes, the inappropriate statistical analyses mean that these findings cannot be considered reliable. Authors' objectives To review the efficacy of antidepressants as a treatment for fibromyalgia syndrome. Searching The following databases were searched to October 2007: MEDLINE, PsycINFO, SCOPUS, and the Cochrane Library. Search terms were reported. Reference lists from included papers and other relevant references were scanned

2008 DARE. PubMed

171. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy (Full text)

Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy Nishishinya B, Urrutia G, Walitt B, Rodriguez A, Bonfill X, Alegre C, Darko G CRD summary The authors concluded that there was some evidence to support the short-term efficacy of amitriptyline 25mg/day for fibromyalgia, but no evidence to support (...) the efficacy of amitriptyline at higher doses or for periods longer than eight weeks. Much of the review was well conducted, but the analyses may be misleading and the overall results should not be considered as reliable. Authors' objectives To review the effectiveness of amitriptyline in the treatment of fibromyalgia. Searching EMBASE, MEDLINE and The Cochrane Library were searched. Search terms and dates were reported. An RCT filter was used and no language restrictions were applied. Databases of ongoing

2008 DARE. PubMed

172. Review: some evidence supports pharmacological and non-pharmacological treatments of fibromyalgia syndrome

Review: some evidence supports pharmacological and non-pharmacological treatments of fibromyalgia syndrome Review: some evidence supports pharmacological and non-pharmacological treatments of fibromyalgia syndrome | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: some evidence supports pharmacological and non-pharmacological treatments of fibromyalgia syndrome Article Text Therapeutics Review: some evidence supports pharmacological

2008 Evidence-Based Medicine (Requires free registration)

173. Grand Rounds: "Fibromyalgia and Homeopathy: Holmes, Hogwarts and the Prince of Wales"

Grand Rounds: "Fibromyalgia and Homeopathy: Holmes, Hogwarts and the Prince of Wales" Grand Rounds: “Fibromyalgia and Homeopathy: Holmes, Hogwarts and the Prince of Wales” – Clinical Correlations Search Grand Rounds: “Fibromyalgia and Homeopathy: Holmes, Hogwarts and the Prince of Wales” February 14, 2008 2 min read Commentary by Nitasha Sarswat MD, PGY-3 This week’s Medicine Grand Rounds speaker was Gerald Weissmann, MD, a familiar face at Bellevue/NYU. He is a professor of rheumatology (...) and the National Center for Complementary and Alternative Medicine and how this mistake cost England millions of pounds that could have been used to fund traditional chemotherapy and save lives. He gave several examples of how the actual doses of key ingredients in homeopathic therapies were negligible: white briony in the product “Head On” and duck extract in “Oscillococcinum.” Dr. Weissman then went on to critique the diagnostic criteria for fibromyalgia set by the American College of Rheumatology

2008 Clinical Correlations

174. A meta-analysis of the efficacy of fibromyalgia treatment according to level of care

A meta-analysis of the efficacy of fibromyalgia treatment according to level of care Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

175. The effectiveness of hydrotherapy in the management of fibromyalgia syndrome: a systematic review

The effectiveness of hydrotherapy in the management of fibromyalgia syndrome: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

176. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

177. Exercise for treating fibromyalgia syndrome. (PubMed)

Exercise for treating fibromyalgia syndrome. Fibromyalgia (FMS) is a syndrome expressed by chronic widespread body pain which leads to reduced physical function and frequent use of health care services. Exercise training is commonly recommended as a treatment. This is an update of a review published in Issue 2, 2002.The primary objective of this systematic review was to evaluate the effects of exercise training including cardiorespiratory (aerobic), muscle strengthening, and/or flexibility

2007 Cochrane

178. Narrative review: the pathophysiology of fibromyalgia. (PubMed)

Narrative review: the pathophysiology of fibromyalgia. Primary fibromyalgia is a common yet poorly understood syndrome characterized by diffuse chronic pain accompanied by other somatic symptoms, including poor sleep, fatigue, and stiffness, in the absence of disease. Fibromyalgia does not have a distinct cause or pathology. Nevertheless, in the past decade, the study of chronic pain has yielded new insights into the pathophysiology of fibromyalgia and related chronic pain disorders. Accruing (...) evidence shows that patients with fibromyalgia experience pain differently from the general population because of dysfunctional pain processing in the central nervous system. Aberrant pain processing, which can result in chronic pain and associated symptoms, may be the result of several interplaying mechanisms, including central sensitization, blunting of inhibitory pain pathways, alterations in neurotransmitters, and psychiatric comorbid conditions. This review provides an overview of the mechanisms

2007 Annals of Internal Medicine

179. Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions (Full text)

Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions van Koulil S, Effting M, Kraaimaat F W, van Lankveld W, van Helmond T, Cats H, van Riel P L, de Jong A J, Haverman J F (...) , Evers A W CRD summary This review examined the effectiveness of non-pharmacological treatments in patients with fibromyalgia. It concluded that, in general, the beneficial effects of non-pharmacological interventions are limited. There were a number of methodological and quality issues with the included studies, but the authors appear to have considered such limitations and their conclusions are likely to be reliable. Authors' objectives To assess the effectiveness of non-pharmacological treatments

2007 DARE. PubMed

180. Acupuncture for fibromyalgia: a systematic review of randomized clinical trials

Acupuncture for fibromyalgia: a systematic review of randomized clinical trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2007 DARE.